Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1992 | 09-1992 | 06-1992 | 03-1992 | 12-1991 | |
| Sales | 2,753 | 3,964 | 1,900 | 467 | 632 |
| Cost of Goods | 0 | 0 | 0 | 0 | -1,102 |
| Gross Profit | 4,876 | 3,247 | 394 | 450 | 1,734 |
| Operating Expenses | 1,229 | 1,225 | 1,214 | 783 | 2,068 |
| Operating Income | 1,524 | 2,740 | 686 | -316 | -436 |
| Interest Expense | -3 | 0 | 2 | 0 | -2 |
| Other Income | 1 | -6 | 56 | -1 | -528 |
| Pre-tax Income | 1,527 | 2,734 | 741 | -317 | -962 |
| Income Tax | 200 | 231 | 0 | 0 | 0 |
| Net Income Continuous | 1,327 | 2,503 | 741 | -317 | -962 |
| Net Income Discontinuous | -1,998,000 | 0 | 0 | 0 | 0 |
| Net Income | $1,327 | $2,503 | $741 | $-317 | $-962 |
| EPS Basic Total Ops | 20,000.00 | 37,500.00 | 11,250.00 | -5,000.00 | N/A |
| EPS Basic Continuous Ops | 13,270.00 | 25,030.00 | 7,410.00 | -3,170.00 | N/A |
| EPS Basic Discontinuous Ops | -19,980,000.00 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 20,000.00 | 37,500.00 | 11,250.00 | -5,000.00 | N/A |
| EPS Diluted Continuous Ops | 13,270.00 | 25,030.00 | 7,410.00 | -5,000.00 | N/A |
| EPS Diluted Discontinuous Ops | -19,980,000.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,524 | $2,740 | $686 | $-316 | $-436 |